SCHEMBL1046372

SCHEMBL1046372

CC(C)(CO)OOC(C)(C)CO

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.32
TDP1 Q9NUW8 2/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9239222 0.90 TSHR (0.50) TSHRTDP1ALDH1A1
SCHEMBL10521475 0.87 TSHR (0.43) TSHRTDP1ALDH1A1
SCHEMBL4752559 0.83
SCHEMBL9245158 0.83 LMNA (0.31)
SCHEMBL7436739 0.77 ALDH1A1 (0.30) TSHRTDP1ALDH1A1
SCHEMBL766523 0.74
SCHEMBL5832169 0.74
SCHEMBL8043487 0.72 ALDH1A1 (0.32) ALDH1A1
SCHEMBL7356273 0.72
SCHEMBL2532258 0.72 ALDH1A1 (0.33) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-6116234-A None JP disclosed
JP-6135927-A None JP disclosed
EP-2960060-B1 LIQUID ACCOMMODATING CONTAINER SEIKO EPSON CORP (JP) 2018-04-11 EP disclosed
US-9498964-B2 Liquid accommodating container SEIKO EPSON CORPORATION (JP) 2016-11-22 US disclosed
US-20160096374-A1 LIQUID ACCOMMODATING CONTAINER SEIKO EPSON CORP (JP) 2016-04-07 US disclosed
US-9238370-B2 Liquid accommodating container SEIKO EPSON CORPORATION (JP) 2016-01-19 US disclosed
EP-2960060-A2 LIQUID ACCOMMODATING CONTAINER Seiko Epson Corporation (JP) 2015-12-30 EP disclosed
US-20150367647-A1 LIQUID ACCOMMODATING CONTAINER SEIKO EPSON CORPORATION (JP) 2015-12-24 US disclosed
US-9108452-B2 Method of manufacturing recorded matter, manufacturing device of recorded matter and recorded matter SEIKO EPSON CORPORATION (JP) 2015-08-18 US disclosed
EP-1944325-B1 PROCESS FOR PRODUCTION OF POLYMER USING IRON COMPLEX AS CATALYST UNIV KYUSHU NAT UNIV CORP (JP) 2014-06-04 EP disclosed
US-8017706-B2 Process for production of polymers with iron complex catalyst DIC CORPORATION (JP) 2011-09-13 US disclosed
US-20110105703-A1 PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST DIC Corporatio (JP) 2011-05-05 US disclosed
EP-2269995-A1 PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST DIC Corporation (JP) 2011-01-05 EP disclosed
CN-101277980-B Process for production of polymer using iron complex as catalyst UNIV KYUSHU NAT UNIV CORP 2010-08-25 CN disclosed
US-7674866-B2 Method of producing polymer using iron complex as catalyst KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2010-03-09 US disclosed
US-20090118448-A1 METHOD OF PRODUCING POLYMER USING IRON COMPLEX AS CATALYST KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATIO (JP) 2009-05-07 US disclosed
CN-101277980-A Process for production of polymer using iron complex as catalyst UNIV KYUSHU NAT UNIV CORP (JP) 2008-10-01 CN disclosed
EP-1944325-A1 PROCESS FOR PRODUCTION OF POLYMER USING IRON COMPLEX AS CATALYST Kyushu University, National University Corporation (JP) 2008-07-16 EP disclosed
JP-H06135927-A DIALKYLPEROXIDE, COMPOSITION USING THE SAME, CROSSLINKING METHOD AND ELECTRIC CABLE NIPPON OIL & FATS CO LTD 1994-05-17 JP disclosed
JP-H06116234-A CROSSLINKING AGENT FOR ETHYLENIC POLYMER, METHOD FOR CROSSLINKING AND ELECTRIC POWER CABLE NIPPON OIL & FATS CO LTD 1994-04-26 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105703-A1 PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST TFRC, FECH, FTH1 TSHR 1575/4885TDP1 4358/4885ALDH1A1 4106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.